AnGes MG,Inc. AnGes MG,Inc. Japanese Site
Home News Releases About Us Projects For Investors
Print
  For Investors
  What's New
  Introduction
  The Company
  Stock performance
  IR Library
HOME > For Investors > What's New
For Investors What's New



What's New
Back Number
January 25, 2012: An Academic Research using “Collategene,” a Treatment Agent for Ischemic Disease was Adopted for a Grant in the UK
- A Research on HGF Gene Therapy for Venous Graft Disease by Bristol University -
December 2, 2011: Research Finding Report on and Academic Society Award for Functional Peptide, “COSMEPEPTIN (TM)”
- Findings on COSMEPEPTIN (TM) reported at Anti-Aging Festa 2011; Anti-Aging Medicine Practices -
November 25, 2011: Development of a Novel Molecular Therapy Agent against Joint Contracture was Adopted as A-STEP by JST
- Development of a Novel Molecular Therapy Agent using “Decoy Nucleotides”-
November 24, 2011: Research Findings concerning Anti-Wrinkle, Anti-Sagging and Anti-Microbial Actions by Functional Peptides, “COSMEPEPTIN (TM)”
- Findings on COSMEPEPTIN (TM) Reported at Nikkei BP Health & Beauty Seminar -
November 10, 2011: For Investors/IR Library: Consolidated Financial Report for the 9 Months Ended September 30, 2011

Copyright 2004 AnGes MG All rights reserved. Contact | Site Map | Site Policy | Privacy Policy